Determination of the upper limit of vulnerability using implantable cardioverter-defibrillator electrograms

Circulation

Volumn 107, Issue 24, 2003, Pages 3028-3033

  Swerdlow, Charles ^a,c   Shivkumar, Kalyanam ^b   Zhang, Jianxin ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

Defibrillation; Fibrillation; Shock

Indexed keywords

ANTIARRHYTHMIC AGENT;

ADULT; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; DATA ANALYSIS; DEFIBRILLATOR; ELECTROCARDIOGRAM; ELECTRODE; FEMALE; HEART REPOLARIZATION; HEART VENTRICLE FIBRILLATION; HUMAN; IMPLANTATION; MALE; PRIORITY JOURNAL; RELIABILITY; T WAVE;

AGED; CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HUMANS; MALE; VENTRICULAR FIBRILLATION;

EID: 0038338572     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000074220.19414.18     Document Type: Article

References (14)

1. Chen PS, Shibata N, Dixon EG, et al. Comparison of the defibrillation threshold and the upper limit of ventricular vulnerability. Circulation. 1986;73:1022-1028.
2. Swerdlow CD, Ahern T, Kass RM, et al. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators. J Am Coll Cardiol. 1996;27:1112-1118.
3. Swerdlow CD, Martin DJ, Kass RM, et al. The zone of vulnerability to T wave shocks in humans. J Cardiovasc Electrophysiol. 1997;8:145-154.
4. Swerdlow CD, Peter CT, Kass RM, et al. Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability. Circulation. 1997;95:1497-1504.
5. Swerdlow CD. Implantation of cardioverter defibrillators without induction of ventricular fibrillation. Circulation. 2001;103:2159-2164.
6. Winfree AT. Sudden cardia death: a problem in topology. Sci Am. 1983;248:144-149.
7. Haws CW, Lux RL. Correlation between in vivo transmembrane action potential durations and activation-recovery intervals from electrograms: effects of interventions that alter repolarization time. Circulation. 1990;81:281-288.
8. Millar CK, Kralios FA, Lux RL. Correlation between refractory periods and activation-recovery intervals from electrograms: effects of rate and adrenergic interventions. Circulation. 1985;72:1372-1379.
9. Wyatt R. Comparison of estimates of activation and recovery times from bipolar and unipolar electrograms to in vivo transmembrane action potential duration. In: Proceedings IEE: Engineering Medical Biologists Society Second Annual Conference. Washington, DC; 1980:22.
10. Yan GX, Antzelevitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation. 1998;98:1928-1936.
11. Taggart P, Sutton PM, Opthof T, et al. Transmural repolarisation in the left ventricle in humans during normoxia and ischaemia. Cardiovasc Res. 2001;50:454-462.
12. Chen PS, Moser KM, Dembitsky WP, et al. Epicardial activation and repolarization patterns in patients with right ventricular hypertrophy. Circulation. 1991;83:104-118.
13. Chinushi M, Tagawa M, Kasai H, et al. Correlation between the effective refractory period and activation-recovery interval calculated from the intracardiac unipolar electrogram of humans with and without dl-sotalol treatment. Jpn Circ J. 2001;65:702-706.
14. Idriss SF, Wolf PD, Smith WM, et al. Effect of pacing site on ventricular fibrillation initiation by shocks during the vulnerable period. Am J Physiol. 1999;277:H2065-H2082.